Zhou, H., Mak, P. Y., Mu, H., Mak, D. H., Zeng, Z., Cortes, J., . . . Carter, B. Z. (2017). Combined inhibition of β-catenin and Bcr–Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and in vivo. Leukemia.

Zhou, H., P Y. Mak, H. Mu, D H. Mak, Z. Zeng, J. Cortes, Q. Liu, M. Andreeff, e B Z. Carter. "Combined Inhibition of β-catenin and Bcr–Abl Synergistically Targets Tyrosine Kinase Inhibitor-resistant Blast Crisis Chronic Myeloid Leukemia Blasts and Progenitors in Vitro and in Vivo." Leukemia 2017.

Zhou, H., et al. "Combined Inhibition of β-catenin and Bcr–Abl Synergistically Targets Tyrosine Kinase Inhibitor-resistant Blast Crisis Chronic Myeloid Leukemia Blasts and Progenitors in Vitro and in Vivo." Leukemia 2017.